tradingkey.logo

GeneDx Holdings Corp

WGS

90.900USD

+11.190+14.04%
Fechamento 06/24, 16:00ETCotações atrasadas em 15 min
2.59BValor de mercado
PerdaP/L TTM

GeneDx Holdings Corp

90.900

+11.190+14.04%
Mais detalhes de GeneDx Holdings Corp Empresa
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
Informações da empresa
Código da empresaWGS
Nome da EmpresaGeneDx Holdings Corp
Data de listagemSep 04, 2020
Fundado em2020
CEOMs. Katherine A. Stueland
Número de funcionários1000
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 04
Endereço333 Ludlow Street
CidadeSTAMFORD
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal06902
Telefone18887291206
Sitehttps://sema4.com/
Código da empresaWGS
Data de listagemSep 04, 2020
Fundado em2020
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
+179.38%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
9.13K
+121.71%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
+179.38%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
9.13K
+121.71%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de abr
Moeda: USDAtualizado em: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Patients with third party insurance
234.70M
76.84%
Institutional customers
65.11M
21.32%
Other
3.29M
1.08%
Self pay patients
2.34M
0.77%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Patients with third party insurance
234.70M
76.84%
Institutional customers
65.11M
21.32%
Other
3.29M
1.08%
Self pay patients
2.34M
0.77%
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Casdin Capital, LLC
12.36%
Corvex Management LP
10.19%
Fidelity Management & Research Company LLC
9.29%
Icahn School of Medicine at Mount Sinai
4.81%
OPKO Health Inc
4.80%
Other
58.54%
Investidores
Investidores
Proporção
Casdin Capital, LLC
12.36%
Corvex Management LP
10.19%
Fidelity Management & Research Company LLC
9.29%
Icahn School of Medicine at Mount Sinai
4.81%
OPKO Health Inc
4.80%
Other
58.54%
Tipos de investidores
Investidores
Proporção
Hedge Fund
34.94%
Investment Advisor/Hedge Fund
30.52%
Investment Advisor
30.22%
Corporation
10.79%
Research Firm
5.64%
Individual Investor
1.54%
Pension Fund
1.15%
Bank and Trust
0.39%
Sovereign Wealth Fund
0.29%
Participação acionária institucional
Atualizado em: ter, 4 de mar
Atualizado em: ter, 4 de mar
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
362
28.77M
101.81%
-353.08K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
2023Q1
296
21.58M
684.27%
+3.47M
2022Q4
305
9.98M
86.27%
+851.42K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Casdin Capital, LLC
3.51M
12.5%
--
--
Dec 31, 2024
Corvex Management LP
2.47M
8.81%
--
--
Dec 31, 2024
Fidelity Management & Research Company LLC
402.39K
1.43%
+348.57K
+647.59%
Dec 31, 2024
Icahn School of Medicine at Mount Sinai
1.37M
4.89%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.88%
-800.83K
-36.88%
Nov 20, 2024
Summit Partners Public Asset Management, LLC
1.43M
5.08%
+671.40K
+88.86%
Feb 05, 2025
William Blair Investment Management, LLC
670.00K
2.39%
+508.67K
+315.31%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.08M
3.85%
+90.95K
+9.20%
Dec 31, 2024
Goldman Sachs & Company, Inc.
1.06M
3.79%
+34.15K
+3.32%
Dec 31, 2024
The Vanguard Group, Inc.
1.00M
3.58%
+156.77K
+18.51%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Atualizado em: sex, 6 de jun
Atualizado em: sex, 6 de jun
Nome
Proporção
Global X Genomics & Biotechnology ETF
2.15%
Simplify Health Care ETF
2.12%
SPDR S&P Health Care Services ETF
1.55%
Harbor Health Care ETF
1.41%
Hypatia Women CEO ETF
0.54%
First Trust Small Cap Growth AlphaDEX Fund
0.53%
Franklin Genomic Advancements ETF
0.38%
First Trust Active Factor Small Cap ETF
0.34%
iShares U.S. Healthcare Providers ETF
0.26%
First Trust Small Cap Core Alphadex Fund
0.26%
Ver Mais
Global X Genomics & Biotechnology ETF
Proporção2.15%
Simplify Health Care ETF
Proporção2.12%
SPDR S&P Health Care Services ETF
Proporção1.55%
Harbor Health Care ETF
Proporção1.41%
Hypatia Women CEO ETF
Proporção0.54%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.53%
Franklin Genomic Advancements ETF
Proporção0.38%
First Trust Active Factor Small Cap ETF
Proporção0.34%
iShares U.S. Healthcare Providers ETF
Proporção0.26%
First Trust Small Cap Core Alphadex Fund
Proporção0.26%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Data
Tipo
Proporção
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
KeyAI